PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
20-Jun-2023 Media Release Zurich, June 20, 2023   Xlife Sciences: shareholders approved all motions at today’s AGM 2023 Xlife Sciences AG
20-Jun-2023 Evotec SE Annual General Meeting 2023 approves all proposed agenda items Evotec SE
20-Jun-2023 CluePoints, Ken Getz & Tufts CSDD and PwC Unveil New RBQM Insights Report at DIA Global Annual Meeting 2023 CluePoints
20-Jun-2023 Agenda Announced for the Annual Pharma CI USA Conference & Exhibition Pharma CI Conference
20-Jun-2023 ADVANZ PHARMA Partners with Veeva to Set Unified Digital-First Commercial Foundation Veeva Systems
20-Jun-2023 Vertebral Compression Fracture Devices Market Size 2023: Anticipated Growth to Reach USD 1.90 Billion by 2030 The Wire Times
20-Jun-2023 CureVac Doses First Patient in Phase 1 Study of Cancer Vaccine Candidate for Surgically Resected Glioblastoma CureVac
20-Jun-2023 CureVac Appoints International Financial Expert Michael Brosnan to Supervisory Board CureVac
20-Jun-2023 NEW ERA OF BIOPRINTING: SET OF BIOINKS ALLOWS COMPLEX HIGH-RESOLUTION BIO-STRUCTURES FROM MICRO- TO MESO-SCALE UpNano
20-Jun-2023 Workplace Wellness Market Predicted to Grow at 5.9% CAGR, Reaching USD 66.20 Billion by 2027 The Wire Times
20-Jun-2023 NEW THEALIPID® EYE DROPS FROM THÉA PROVIDE LONG-LASTING SYMPTOM RELIEF OF DRY EYE THÉA
20-Jun-2023 Intravenous Therapy and Vein Access Market Projected to Grow Expeditiously: to Reach USD 37.5 Billion by 2030, Report The Wire Times
20-Jun-2023 Santhera Grants Exclusive North America License for Vamorolone to Catalyst Pharmaceuticals in Deal Valued at up to USD 231 Million Plus Royalties Santhera Pharmaceuticals
20-Jun-2023 Lupin Healthcare launches Beclu® (beclometasone dipropionate) certified carbon neutral inhalers for the treatment of asthma in the UK1,2,3 Lupin Healthcare
20-Jun-2023 Real-world evidence study shows the significant impact of hyperkalaemia on cardiorenal patient outcomes AstraZeneca
20-Jun-2023 Safety Needles Market Projected to Exceed $3 Billion by 2026, Witnessing an Unyielding CAGR of 8.1% The Wire Times
20-Jun-2023 Real-world evidence highlights the urgent need to act on the growing global burden of chronic kidney disease AstraZeneca
20-Jun-2023 Disease X is coming. Are we ready? Merit
20-Jun-2023 MIMETAS and Astellas Expand Partnership to Include Automation and Application Support MIMETAS
20-Jun-2023 Completion of ISO 13485 Certification Audit Spectral MD Holdings, Ltd